PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9065177::ACT052882

MP

Evidence text

Paper-level observation

The potential of the stapled MP peptides to non-specifically lyse red blood cells (RBC) was measured and their hemolytic activities (HC50) determined. The peptide MP9 displayed the lowest level of RBC hemolysis.
textConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Hemolytic
Measure
HD50
Comparator
=
Raw observation
HC50 values not explicitly given for MP; MP9 displayed the lowest level of RBC hemolysis
Normalized measurement
=0 µM
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
INLKALAALAKKIL
Standardization
ready simple

Source publication

Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.

Theranostics · 2022

DOI 10.7150/thno.71129 PMC9065177
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003679PEPDIA-INT-081761

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.